Ascent Translational Sciences provides comprehensive consultative services in the commercial development of start-up and Fortune 500 companies in the area of bio tech and medical device space.
Currently, Dr. Mary Russell as President of Ascent Translational Sciences, assists clients with clinical and regulatory strategy development, integrating preclinical, clinical and market development programs to maximize commercial success.
Ascent Translational Sciences concept to commercial planning leverages an early strategy focused on acceleration by integrated an parallel development and building data continuum towards market leadership.
Key areas of concentration